Royce & Associates LP Acquires 51,955 Shares of Owens & Minor, Inc. (NYSE:OMI)

Royce & Associates LP increased its holdings in Owens & Minor, Inc. (NYSE:OMIFree Report) by 179.4% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 80,914 shares of the company’s stock after buying an additional 51,955 shares during the quarter. Royce & Associates LP owned about 0.10% of Owens & Minor worth $1,270,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of Owens & Minor by 1.9% in the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock worth $242,459,000 after acquiring an additional 162,182 shares during the period. Deerfield Management Company L.P. Series C grew its position in Owens & Minor by 30.6% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock worth $86,014,000 after purchasing an additional 1,493,852 shares during the period. Dimensional Fund Advisors LP raised its stake in Owens & Minor by 1.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company’s stock valued at $61,213,000 after buying an additional 76,599 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Owens & Minor by 16.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock valued at $16,829,000 after buying an additional 176,250 shares during the period. Finally, Dana Investment Advisors Inc. boosted its stake in shares of Owens & Minor by 35.8% in the 2nd quarter. Dana Investment Advisors Inc. now owns 609,040 shares of the company’s stock worth $8,222,000 after buying an additional 160,682 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Wall Street Analysts Forecast Growth

OMI has been the subject of a number of research reports. Robert W. Baird reduced their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. Barclays lowered their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. UBS Group cut their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Citigroup decreased their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research report on Wednesday, August 21st. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Owens & Minor presently has a consensus rating of “Hold” and an average price target of $18.50.

Read Our Latest Stock Report on OMI

Owens & Minor Stock Up 1.2 %

Owens & Minor stock opened at $12.41 on Wednesday. The business has a fifty day moving average price of $13.92 and a 200-day moving average price of $15.30. The stock has a market capitalization of $956.94 million, a price-to-earnings ratio of -19.09, a PEG ratio of 0.42 and a beta of 0.41. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor, Inc. has a 1-year low of $11.42 and a 1-year high of $28.35.

Owens & Minor (NYSE:OMIGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.44 earnings per share. Equities research analysts forecast that Owens & Minor, Inc. will post 1.49 EPS for the current fiscal year.

About Owens & Minor

(Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Articles

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.